COLLINSONIA CANADENSIS (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the COLLINSONIA CANADENSIS drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: COLLINSONIA CANADENSIS
SUBSTANCE NAME: COLLINSONIA CANADENSIS ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-10-02
END MARKETING DATE: 0000-00-00


COLLINSONIA CANADENSIS HUMAN OTC DRUG Details:

Item DescriptionCOLLINSONIA CANADENSIS from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 2015-10-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-0151_d9a51878-88ac-481d-9b6b-0ecde8200576
PRODUCT NDC: 15631-0151
APPLICATION NUMBER:

Other COLLINSONIA CANADENSIS ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.COLLINSONIA CANADENSIS
Paramesh Banerji Life Sciences LLCCollinsonia canadensis 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCOLLINSONIA CANADENSIS
Washington Homeopathic ProductsCollinsonia canadensis